In fact, TGF-β is a strong inducer of EMT in PDAC cells, and pancreatic cancer cells acquire chemotherapeutic resistance through the activation of the TGF-β signaling pathway, which promotes EMT11,43. This evidence concerns the gene TGFB1 and pancreatic neoplasm.